The health regulator has been slammed for hindering growth in the cannabis industry after it classified a cannabis oil compound as a prescription medicine, and some in the sector say slow regulatory reform is also holding back progress.

“We've moved backwards because now they are saying even the non-psychoactive cannabinoids are schedule 6, which makes zero sense and is outside what's happening globally,”  said Gabriel Theron, CEO and founder of Cilo Cybin said...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.